Clinical Trial: Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian Cancer
Clinical Trial: Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian CancerSponsor and Collaborators
Women and Infants Hospital of Rhode Island
National Cancer Institute (NCI)
Contact
Contact: Clinical Trials Office - Women and Infants Hospital of Rhode I
401-274-1122
Principal Investigator
Laurent Brard, MD, PhD, FACOG Women and Infants Hospital of Rhode Island
ClinicalTrials.gov Identifier
NCT00986206
